Advertisement

Topics

Janssen’s Scott Plevy Joins Synlogic as Chief Scientific Officer

18:18 EDT 16 Apr 2019 | Xconomy

Synlogic (NASDAQ: SYBX) has appointed Scott Plevy to serve as chief scientific officer. A gastroenterologist, Plevy was most recently a vice president in gastroenterology disease at Janssen Research & Development. Cambridge, MA-based Synlogic is developing drugs that employ engineered microbes to treat metabolic and inflammatory diseases, as well as cancer.

Original Article: Janssen’s Scott Plevy Joins Synlogic as Chief Scientific Officer

NEXT ARTICLE

More From BioPortfolio on "Janssen’s Scott Plevy Joins Synlogic as Chief Scientific Officer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...